1
Benjamin Oshlack, Robert Colucci, Curtis Wright, Christopher Breder: Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent. Euro Celtique, Philip C Strassburger, Alan L Koller, December 5, 2006: US07144587 (111 worldwide citation)

Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and a bittering agent in an effective amount to impart a bitter taste to an abuser upon administration of the dosage form after tampering.


2
Benjamin Oshlack, Robert Colucci, Curtis Wright, Christopher Breder: Pharmaceutical formulation containing bittering agent. Euro Celtique, Philip C Strassburger, Alan L Koller, November 28, 2006: US07141250 (105 worldwide citation)

Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of a bittering agent to impart a bitter taste to an abuser upon administration of said dosage form after tampering.


3
Curtis Wright, Benjamin Oshlack, Christopher Breder: Pharmaceutical formulation containing gelling agent. Purdue Pharma, Lowenstein Sandler PC, December 25, 2012: US08337888 (87 worldwide citation)

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart ...


4
Benjamin Oshlack, Curtis Wright, Christopher Breder: Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent. Purdue Pharma, Davidson Davidson & Kappel, November 30, 2010: US07842307 (87 worldwide citation)

Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist and one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity un ...


5
Curtis Wright, Benjamin Oshlack, Christopher Breder: Pharmaceutical composition containing gelling agent. Purdue Pharma, The P F Laboratories, Purdue Pharmaceuticals, Lowenstein Sandler PC, March 5, 2013: US08389007 (41 worldwide citation)

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart ...


6
Benjamin Oshlack, Curtis Wright, Christopher Breder: Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent. Purdue Pharma, The P F Laboratories, Purdue Pharmaceuticals, Davidson Davidson & Kappel, September 3, 2013: US08524275 (38 worldwide citation)

Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist and one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity un ...


7
Curtis Wright, Benjamin Oshlack, Christopher Breder: Pharmaceutical formulation containing gelling agent. Purdue Pharma, The P F Laboratories, Purdue Pharmaceuticals, Lowenstein Sandler, December 17, 2013: US08609683 (35 worldwide citation)

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart ...


8
Curtis Wright, Benjamin Oshlack, Christopher Breder: Pharmaceutical formulation containing gelling agent. Purdue Pharma, The P F Laboratories, Purdue Pharmaceuticals, Lowenstein Sandler, September 10, 2013: US08529948 (31 worldwide citation)

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart ...


9
Christopher Breder, Benjamin Oshlack, Curtis Wright: Sequestered antagonist formulations. Purdue Pharma, Davidson Davidson & Kappel, June 18, 2013: US08465774 (23 worldwide citation)

Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact, such that the ratio of the mean Cmax of the antagonist after single dose oral administration ...


10
Curtis Wright, Benjamin Oshlack, Christopher Breder: Pharmaceutical formulation containing gelling agent. Purdue Pharma, The P F Laboratories, Purdue Pharmaceuticals, Lowenstein Sandler, October 28, 2014: US08871265 (21 worldwide citation)

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart ...